These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

953 related articles for article (PubMed ID: 28030794)

  • 1. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
    Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J
    Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated Analysis and MicroRNA Expression Profiling Identified Seven miRNAs Associated With Progression of Oral Squamous Cell Carcinoma.
    Yan ZY; Luo ZQ; Zhang LJ; Li J; Liu JQ
    J Cell Physiol; 2017 Aug; 232(8):2178-2185. PubMed ID: 27935034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
    Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
    J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.
    Romani C; Salviato E; Paderno A; Zanotti L; Ravaggi A; Deganello A; Berretti G; Gualtieri T; Marchini S; D'Incalci M; Mattavelli D; Piazza C; Bossi P; Romualdi C; Nicolai P; Bignotti E
    Theranostics; 2021; 11(6):2987-2999. PubMed ID: 33456584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microRNA-21 (MIR-21) and phosphatase and tensin homolog (PTEN) are promising novel biomarkers for detection of oral squamous cell carcinoma.
    Ren W; Qiang C; Gao L; Li SM; Zhang LM; Wang XL; Dong JW; Chen C; Liu CY; Zhi KQ
    Biomarkers; 2014 Nov; 19(7):590-6. PubMed ID: 25174622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A circulating microRNA panel as a novel dynamic monitor for oral squamous cell carcinoma.
    Piao Y; Jung SN; Lim MA; Oh C; Jin YL; Kim HJ; Nguyen QK; Chang JW; Won HR; Koo BS
    Sci Rep; 2023 Feb; 13(1):2000. PubMed ID: 36737651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma.
    Hou B; Ishinaga H; Midorikawa K; Shah SA; Nakamura S; Hiraku Y; Oikawa S; Murata M; Takeuchi K
    Cancer Biol Ther; 2015; 16(7):1042-6. PubMed ID: 25950115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-200b-3p in plasma is a potential diagnostic biomarker in oral squamous cell carcinoma.
    Sun G; Cao Y; Wang P; Song H; Bie T; Li M; Huai D
    Biomarkers; 2018 Mar; 23(2):137-141. PubMed ID: 28135849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
    Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N
    Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
    Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
    Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-based classifiers for diagnosis of oral cavity squamous cell carcinoma in tissue and plasma.
    Pedersen NJ; Jensen DH; Lelkaitis G; Kiss K; Charabi BW; Ullum H; Specht L; Schmidt AY; Nielsen FC; von Buchwald C
    Oral Oncol; 2018 Aug; 83():46-52. PubMed ID: 30098778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-generation Sequencing for microRNA Profiling: MicroRNA-21-3p Promotes Oral Cancer Metastasis.
    Tseng HH; Tseng YK; You JJ; Kang BH; Wang TH; Yang CM; Chen HC; Liou HH; Liu PF; Ger LP; Tsai KW
    Anticancer Res; 2017 Mar; 37(3):1059-1066. PubMed ID: 28314265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Three-MicroRNA Signature as a Potential Biomarker for the Early Detection of Oral Cancer.
    Chang YA; Weng SL; Yang SF; Chou CH; Huang WC; Tu SJ; Chang TH; Huang CN; Jong YJ; Huang HD
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.
    Manikandan M; Deva Magendhra Rao AK; Rajkumar KS; Rajaraman R; Munirajan AK
    J Oral Pathol Med; 2015 Nov; 44(10):792-800. PubMed ID: 25482863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating MicroRNA-21 Expression as a Novel Serum Biomarker for Oral Sub-Mucous Fibrosis and Oral Squamous Cell Carcinoma.
    Singh P; Srivastava AN; Sharma R; Mateen S; Shukla B; Singh A; Chandel S
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):1053-1057. PubMed ID: 29699056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma.
    Gai C; Camussi F; Broccoletti R; Gambino A; Cabras M; Molinaro L; Carossa S; Camussi G; Arduino PG
    BMC Cancer; 2018 Apr; 18(1):439. PubMed ID: 29669525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
    Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
    J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the Presence of Oral Squamous Cell Carcinoma Using Commonly Dysregulated MicroRNA in Oral Swirls.
    Yap T; Koo K; Cheng L; Vella LJ; Hill AF; Reynolds E; Nastri A; Cirillo N; Seers C; McCullough M
    Cancer Prev Res (Phila); 2018 Aug; 11(8):491-502. PubMed ID: 29764807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
    Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
    Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctive expression signatures of serum microRNAs in ischaemic stroke and transient ischaemic attack patients.
    Wu J; Fan CL; Ma LJ; Liu T; Wang C; Song JX; Lv QS; Pan H; Zhang CN; Wang JJ
    Thromb Haemost; 2017 May; 117(5):992-1001. PubMed ID: 28251236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.